1. Can we improve the negative predictive value of faecal calprotectin for the diagnosis of IBS in primary care?. (13th March 2011) Authors: Zayyat, R; Appleby, R N; Logan, R P H Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunosuppression, IBD, and risk of lymphoma. Issue 2 (1st August 2002) Authors: Bebb, J R; Aithal, G P; Logan, R P H Journal: Gut Issue: Volume 51:Issue 2(2002) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-087 Can faecal calprotectin reduce the demand for colonoscopy in patients with irritable bowel syndrome?. (23rd September 2015) Authors: Whitehead, S J; Lee, L; Fang, Z; Sisson, G; Hutton, J; Logan, R P H Journal: Gut Issue: Volume 59(2010)Supplement 1 Page Start: A36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Reply. Issue 5 (May 1991) Authors: Logan, R P H; Misiewicz, J J; Dill, S Journal: Gut Issue: Volume 32:Issue 5(1991) Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Urea breath tests in teh management of Helicobacter pylori infection. (1st July 1998) Authors: Logan, R P H Journal: Gut Issue: Volume 43(1998)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗